Chen, Jinghong
Zuo, Zhixiang
Gao, Yan
Yao, Xiaosai
Guan, Peiyong
Wang, Yali
Li, Zhimei
Liu, Zhilong
Hong, Jing Han
Deng, Peng
Chan, Jason Yongsheng
Cheah, Daryl Ming Zhe
Lim, Jingquan
Chai, Kelila Xin Ye
Chia, Burton Kuan Hui
Pang, Jane Wan Lu
Koh, Joanna
Huang, Dachuan
He, Haixia
Sun, Yichen
Liu, Lizhen
Liu, Shini
Huang, Yuhua
Wang, Xiaoxiao
You, Hua
Saraf, Sahil Ajit
Grigoropoulos, Nicholas Francis
Li, Xiaoqiu
Bei, Jinxin
Kang, Tiebang
Lim, Soon Thye
Teh, Bin Tean
Huang, Huiqiang
Ong, Choon Kiat
Tan, Jing
Clinical trials referenced in this document:
Documents that mention this clinical trial
Aberrant JAK-STAT signaling-mediated chromatin remodeling impairs the sensitivity of NK/T-cell lymphoma to chidamide
https://doi.org/10.1186/s13148-023-01436-6
Funding for this research was provided by:
Medical Scientific Research Foundation of Guangdong Province of China (A2016013)
National Natural Science Foundation of China (81970176, 81972596)
Singapore National Medical Research Council (NMRC-TCR-12Dec005)
National Cancer Centre Research Fund (NCCRF-OACPCCS-YR2015-AUG2)
Neighborhood Funders Group Fund (NMRC/TA/0051/2016)
Tanoto Foundation
Ling Foundation
New Century Foundation
Guangdong Innovative and Entrepreneurial Research Team Program (2016ZT06S638)
Sci-Tech Project Foundation of Guangzhou City (201707020039)
Article History
Received: 3 November 2022
Accepted: 29 January 2023
First Online: 6 February 2023
Declarations
:
: The study was approved by the institutional review board of SYSUCC in accordance with the Declaration of Helsinki, and applicable regulations according to Good Clinical Practice guidelines. Written informed consent was obtained from all patients before enrollment in the trial. This trial was registered at ClinicalTrials.gov, number NCT02878278. Research protocols for tumor collection and analysis were approved by the ethical committees of the SYSUCC. In vivo studies were conducted in compliance with animal protocols approved by the SingHealth Institutional Animal Care and Use Committee.
: All authors have agreed to publish this manuscript.
: The authors declare that they have no competing interests.